Document is current
Any future updates will be listed below
-
Authors
Belperio, John
Nguyen, Tuan
Lombardi, David A
Bogus, Maxim
Moskalenko, Valentyn
Singh, Dave
Haumann, Brett
Bourdet, David L
Kaufman, Elad
Pfeifer, Nathan D
Thompson, Corbin G
Woo, Jacky
Moran, Edmund J
Saggar, Rajeev
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04402866 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
https://doi.org/10.1136/bmjresp-2023-001627
Large scale clinical trials: lessons from the COVID-19 pandemic
https://doi.org/10.1136/bmjresp-2022-001226
JAK inhibitors and COVID-19
https://doi.org/10.1136/jitc-2021-002838
-
Funding
Funding for this research was provided by:
Theravance Biopharma Ireland Limited (Not applicable)
- License Information
